发明名称 |
QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS |
摘要 |
The present invention discloses compounds of formula I and II or pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
|
申请公布号 |
CA2705807(A1) |
申请公布日期 |
2009.05.22 |
申请号 |
CA20082705807 |
申请日期 |
2008.11.14 |
申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
GAI, YONGHUA;OR, YAT SUN;WANG, ZHE |
分类号 |
A01N43/60;A61K31/495 |
主分类号 |
A01N43/60 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|